<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20446" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Diabetic Peripheral Neuropathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bodman</surname>
            <given-names>Myron A.</given-names>
          </name>
          <aff>Kent State University CPM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dreyer</surname>
            <given-names>Mark A.</given-names>
          </name>
          <aff>Intercoastal Medical Group</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varacallo</surname>
            <given-names>Matthew</given-names>
          </name>
          <aff>Penn Highlands Healthcare System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Myron Bodman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Dreyer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Varacallo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20446.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Peripheral neuropathy encompasses a broad range of clinical pathologies potentially presenting with peripheral nervous system dysfunction. Patients with&#x000a0;peripheral neuropathy&#x000a0;often present with varying degrees of numbness, tingling, aching, burning sensation, weakness of limbs, hyperalgesia, allodynia, and pain. Neuropathic pain has been characterized as superficial, deep-seated, or severe, unremitting pain with exacerbation at night.&#x000a0;While metabolic disorders represent the predominant etiology of extremity pain caused by an underlying peripheral neuropathy clinical pathology, broad clinical consideration is given to many clinical conditions. There are many possible&#x000a0;causes of peripheral neuropathy; the most prevalent subtype, diabetic peripheral neuropathy (DPN), can lead to significant complications ranging from paresthesia to loss of limb and life.&#x000a0;</p>
        <p>Because peripheral neuropathy is so common in patients with diabetes, the American Diabetes Association (ADA) recommends clinicians evaluate patients with type 2 diabetes when they are diagnosed; in patients with type 1 diabetes, clinicians should assess for peripheral neuropathy 5 years after diagnosis and then annually. Peripheral neuropathy is primarily diagnosed clinically. Diabetic peripheral neuropathy management consists of several strategies.&#x000a0;The aim of this activity is to enhance healthcare learners' competence in selecting appropriate diagnostic tests, managing&#x000a0;peripheral neuropathy, and fostering effective interprofessional teamwork to improve outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology of diabetic peripheral neuropathy.</p></list-item><list-item><p>Implement evidence-based treatment strategies for diabetic peripheral neuropathy.</p></list-item><list-item><p>Determine&#x000a0;the potential complications of diabetic peripheral neuropathy.</p></list-item><list-item><p>Implement collaboration strategies with interprofessional team members to provide well-coordinated care and enhance patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20446&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20446">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20446.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Peripheral neuropathy encompasses a broad range of clinical pathologies potentially presenting with peripheral nervous system dysfunction.<xref ref-type="bibr" rid="article-20446.r1">[1]</xref>&#x000a0;Patients with peripheral neuropathy often present with varying degrees of numbness, tingling, aching, burning sensation, weakness of limbs, hyperalgesia, allodynia, and pain. This pain has been characterized as superficial, deep-seated, or severe, unremitting pain with exacerbation at night.<xref ref-type="bibr" rid="article-20446.r2">[2]</xref> While metabolic disorders represent the predominant etiology of extremity pain caused by an underlying peripheral neuropathy clinical pathology, broad clinical consideration is given&#x000a0;to many clinical conditions.</p>
        <p>Although there are many possible&#x000a0;causes of peripheral neuropathy, the most prevalent subtype, diabetic peripheral neuropathy (DPN), can lead to significant complications ranging from paresthesia to loss of limb and life.<xref ref-type="bibr" rid="article-20446.r2">[2]</xref> Early assessment of symptoms of peripheral polyneuropathy helps avoid neuropathic foot ulcers to combat&#x000a0;potential morbidity and mortality resulting from the pathophysiologic&#x000a0;poor wound healing potential, which can lead to limb compromise, local&#x000a0;to systemic infection, septicemia, and&#x000a0;even death.<xref ref-type="bibr" rid="article-20446.r3">[3]</xref><xref ref-type="bibr" rid="article-20446.r4">[4]</xref><xref ref-type="bibr" rid="article-20446.r5">[5]</xref>&#x000a0;DPN is primarily diagnosed clinically through history and neurological assessment of small fiber sensation with temperature changes or pinpricks, large fiber sensation with vibrations, and ulceration risk with pressure testing using a 10 g monofilament. Neurology consultation and specialized testing, including nerve conduction studies and intraepidermal nerve fiber density testing, are only indicated for patients with atypical clinical features (eg, rapid symptom onset, severe neuromotor impairment, and asymmetrically abnormal sensation).<xref ref-type="bibr" rid="article-20446.r6">[6]</xref></p>
        <p>The exact cause of DPN is not known. Proposed theories include metabolic, neurovascular, and&#x000a0;autoimmune pathways&#x000a0;have been&#x000a0;proposed. Mechanical compression (eg, carpal tunnel), genetics, and social and lifestyle factors such&#x000a0;as chronic alcohol consumption and smoking have all been implicated. Perpetually high blood serum glucose leads to insulin resistance, promoting oxidative stress, inflammation, and cell damage.<xref ref-type="bibr" rid="article-20446.r7">[7]</xref> First, the distal sensory and autonomic nerve fibers are damaged;&#x000a0;the damage continues with proximal progression, leading to a gradual loss of protective&#x000a0;sensation&#x000a0;in the skin and foot joints. DPN management consists of several strategies, including preventative measures (eg, patient education, proper foot care, correct shoe wear, and annual foot exam), glucose control, dietary modifications, weight loss, and pain control. Half of the diabetic peripheral neuropathies may be asymmetric.<xref ref-type="bibr" rid="article-20446.r6">[6]</xref> If not recognized and preventative foot care is not implemented, patients have an increased risk of injury due to their insensate feet.<xref ref-type="bibr" rid="article-20446.r8">[8]</xref><xref ref-type="bibr" rid="article-20446.r9">[9]</xref></p>
      </sec>
      <sec id="article-20446.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Metabolic disorders represent the most common clinical category of etiologies, causing extremity pain from underlying&#x000a0;peripheral neuropathy&#x000a0;conditions.&#x000a0;Several causes&#x000a0;of PN exist, but diabetes mellitus is the most common etiology. Other underlying etiologies include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alcohol use disorder&#x000a0;<xref ref-type="bibr" rid="article-20446.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Nutritional deficiencies (eg, low B12, high B6)&#x000a0;<xref ref-type="bibr" rid="article-20446.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Guillain-Barre syndrome&#x000a0;<xref ref-type="bibr" rid="article-20446.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Toxins (eg, chemotherapy) and overdose&#x000a0;<xref ref-type="bibr" rid="article-20446.r13">[13]</xref><xref ref-type="bibr" rid="article-20446.r14">[14]</xref><xref ref-type="bibr" rid="article-20446.r15">[15]</xref><xref ref-type="bibr" rid="article-20446.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Hereditary or genetic conditions (eg, Charcot Marie Tooth disease, amyloidosis, porphyria)&#x000a0;<xref ref-type="bibr" rid="article-20446.r17">[17]</xref><xref ref-type="bibr" rid="article-20446.r18">[18]</xref><xref ref-type="bibr" rid="article-20446.r19">[19]</xref><xref ref-type="bibr" rid="article-20446.r20">[20]</xref><xref ref-type="bibr" rid="article-20446.r21">[21]</xref><xref ref-type="bibr" rid="article-20446.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Infection (eg, HIV)<xref ref-type="bibr" rid="article-20446.r23">[23]</xref><xref ref-type="bibr" rid="article-20446.r24">[24]</xref><xref ref-type="bibr" rid="article-20446.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p>Inflammatory conditions (eg, lupus and rheumatoid arthritis)&#x000a0;<xref ref-type="bibr" rid="article-20446.r26">[26]</xref><xref ref-type="bibr" rid="article-20446.r27">[27]</xref>]<xref ref-type="bibr" rid="article-20446.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Hypothyroidism&#x000a0;<xref ref-type="bibr" rid="article-20446.r29">[29]</xref><xref ref-type="bibr" rid="article-20446.r30">[30]</xref><xref ref-type="bibr" rid="article-20446.r31">[31]</xref><xref ref-type="bibr" rid="article-20446.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Trauma&#x000a0;<xref ref-type="bibr" rid="article-20446.r33">[33]</xref><xref ref-type="bibr" rid="article-20446.r34">[34]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Diabetic Peripheral Neuropathy Risk Factors&#x000a0;</bold>
</p>
        <p>Risk factors for DPN include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Advanced age</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Peripheral vascular disease</p>
          </list-item>
          <list-item>
            <p>Smoking</p>
          </list-item>
          <list-item>
            <p>Dyslipidemia</p>
          </list-item>
          <list-item>
            <p>Poor glucose control</p>
          </list-item>
          <list-item>
            <p>Long-standing diabetes</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Excessive alcohol consumption</p>
          </list-item>
          <list-item>
            <p>Positive <italic toggle="yes">HLA-DR3/4</italic> genotype</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20446.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>At the time a patient is diagnosed with diabetes, the literature estimates that 10% to 20% of these patients are concomitantly diagnosed with DPN; however, studies analyzing patients with long-standing diabetes mellitus report that DPN has a higher prevalence in those patients. After 5 years, 26% have peripheral neuropathy, and 41% of patients with diabetes have neuropathy at 10 years.&#x000a0;The literature reports that 50% to 66% of patients with diabetes mellitus will eventually develop DPN during their lifetime.<xref ref-type="bibr" rid="article-20446.r35">[35]</xref>&#x000a0;DPN can occur in both type 1 and type 2 diabetes, but the prevalence is higher in individuals with type 2 diabetes due to the longer duration and higher rates of comorbidities.<xref ref-type="bibr" rid="article-20446.r36">[36]</xref>&#x000a0;Diabetes mellitus is also the most common cause of Charcot neuroarthropathy, with an incidence of 0.1% to 0.4% and as high as 29% in patients with peripheral neuropathy.<xref ref-type="bibr" rid="article-20446.r37">[37]</xref></p>
        <p>About half of patients with DPN can clinically present with asymmetric sensory changes.<xref ref-type="bibr" rid="article-20446.r38">[38]</xref><xref ref-type="bibr" rid="article-20446.r39">[39]</xref>&#x000a0;Obesity and genetic factors increase the risk of developing diabetes. Peripheral and autonomic neuropathies are some of the leading causes of morbidity in diabetes mellitus. At 5 years, the risk of death for patients with a diabetic foot ulcer is 2.5 times as high as the risk of death for a patient with diabetes who does not have a foot ulcer. The rate of emergency department visits for diabetic foot ulcers and associated infection exceeds the rates for congestive heart failure, renal disease, depression, and most forms of cancer.<xref ref-type="bibr" rid="article-20446.r40">[40]</xref><xref ref-type="bibr" rid="article-20446.r41">[41]</xref><xref ref-type="bibr" rid="article-20446.r42">[42]</xref></p>
      </sec>
      <sec id="article-20446.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>DPN encompasses sensory, motor, and autonomic neuropathy. Increased serum glucose leads to insulin resistance, dyslipidemia, and oxidative stress of the endoplasmic reticulum and mitochondria. These processes contribute to accumulating reactive oxygen species (ROS), inflammation, and cellular damage. The infiltrated macrophages inside peripheral nerve cells trigger cytokine and chemokine production, promoting inflammation and nerve fiber damage.<xref ref-type="bibr" rid="article-20446.r7">[7]</xref> In addition, implicated causes of peripheral nerve damage include advanced glycosylation end products and disturbance of hexosamine, protein kinase C, and polymerase pathways. Neurovascular impairment with poor repair processes and endothelial dysfunction&#x000a0;also&#x000a0;have been implicated.<xref ref-type="bibr" rid="article-20446.r39">[39]</xref></p>
      </sec>
      <sec id="article-20446.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Transient hyperglycemia is often tolerated by normal compensatory physiological&#x000a0;function and homeostatic mechanisms of blood sugar control. However, serum glucose can have toxic effects such as neuropathy in chronically elevated states. For patients diagnosed early with type 1 diabetes, tight glucose control can reduce the risk of diabetic peripheral neuropathy by 78%.<xref ref-type="bibr" rid="article-20446.r36">[36]</xref>&#x000a0;In contrast, typically, with a later diagnosis of long-standing hyperglycemia or type 2 diabetes, tight glucose control only reduces the risk by 5% to 9%.<xref ref-type="bibr" rid="article-20446.r36">[36]</xref><xref ref-type="bibr" rid="article-20446.r43">[43]</xref></p>
      </sec>
      <sec id="article-20446.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Because peripheral neuropathy is so common in patients with diabetes, the American Diabetes Association (ADA) recommends clinicians evaluate patients with type 2 diabetes when they are diagnosed; in patients with type 1 diabetes, clinicians should assess for peripheral neuropathy 5 years after diagnosis and then annually. Peripheral neuropathy is primarily diagnosed clinically through history and neurological assessment of small fiber sensation with temperature changes or pinpricks, large fiber sensation with vibrations, and ulceration risk with pressure testing using a 10 g monofilament.<xref ref-type="bibr" rid="article-20446.r6">[6]</xref></p>
        <p>
<bold>Clinical History</bold>
</p>
        <p>Clinicians should perform a complete medical history, including diabetes, obesity, dyslipidemia, and hypertension. Furthermore, a review of systems and medications captures most of the underlying causes of DPN. Other risk factors for&#x000a0;peripheral neuropathy should also be noted (eg, older age and diabetes control). Characteristic symptoms of peripheral neuropathy include burning, numbness, or tingling in the feet that worsens at night.<xref ref-type="bibr" rid="article-20446.r6">[6]</xref> Patients with pedal paresthesias and dysesthesia often describe&#x000a0;a nonspecific constellation of symptoms&#x000a0;resulting in difficulty with&#x000a0;ambulation&#x000a0;and other basic activities of daily living (ADL). Clinical features of peripheral neuropathy and distal sensory peripheral neuropathy are present in about 80% of DPN patients, often described&#x000a0;as a "stocking-glove distribution," which&#x000a0;can take several years to develop.<xref ref-type="bibr" rid="article-20446.r44">[44]</xref></p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>A lower extremity neurological physical exam should include muscle strength, reflex, and sensation evaluation, including light touch with a monofilament, vibratory sensation, and proprioception. A dermatological exam demonstrating dry/cracked skin may point to autonomic neuropathy, while pedal deformities (eg, hammertoes) suggest motor neuropathy.<xref ref-type="bibr" rid="article-20446.r44">[44]</xref></p>
        <p>Small fiber sensation is assessed with temperature changes or pinprick testing. A patient's risk for developing ulcers is evaluated by determining the individual's ability to feel pressure. Since the protective sensation is lost after sensory impairment, the standard Semmes-Weinstein 5.07 monofilament 10 g of pressure protective sensation test may be accurately sensed even after developing a neurotrophic ulcer.<xref ref-type="bibr" rid="article-20446.r6">[6]</xref></p>
        <p>Large fibers are assessed through vibratory sensation.<xref ref-type="bibr" rid="article-20446.r6">[6]</xref> Simply timing the duration that a vibrating 128 Hz tuning fork is felt at the dorsal hallux interphalangeal joint, normally 18 seconds in most individuals, can be used to&#x000a0;detect sensory deficits earlier and quantify severity. Decreased light touch sensation or loss of ankle reflexes&#x000a0;tend&#x000a0;to&#x000a0;occur earlier in the disease&#x000a0;process. In contrast, the&#x000a0;detectable&#x000a0;loss of protective sensation tends to occur later in the disease, sometimes even after a neuropathic ulcer develops. Needle electromyography (EMG)&#x000a0;and nerve conduction velocity testing can be both painful and expensive and mainly test the large myelinated fibers. Epidermal nerve fiber density testing can be performed to evaluate the small unmyelinated fibers.<xref ref-type="bibr" rid="article-20446.r45">[45]</xref></p>
        <p>
<bold>Autonomic Symptoms</bold>
</p>
        <p>Autonomic neuropathy is also prevalent in diabetes and can affect the gastrointestinal, cardiovascular, and genitourinary organs. Common symptoms in each organ system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>GI: Abdominal discomfort, dysphagia, nausea, fecal incontinence, constipation, diarrhea</p>
          </list-item>
          <list-item>
            <p>Cardiac: Hypotension, sinus tachycardia, variable heart rate, syncope</p>
          </list-item>
          <list-item>
            <p>Bladder: Weak urinary stream, straining to void, incomplete emptying of bladder,&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Skin: Heat intolerance, gustatory sweating, extreme diaphoresis</p>
          </list-item>
          <list-item>
            <p>Nervous: Carpal tunnel syndrome, radiculopathy, lumbosacral, cervical neuropathy, and impairment of cranial nerves III, IV, VI, and VII</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20446.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Neurology consultation and specialized testing, including nerve conduction studies and intraepidermal nerve fiber density testing, are only indicated for patients with atypical clinical features (eg, rapid symptom onset, severe neuromotor impairment, and asymmetrically abnormal sensation).<xref ref-type="bibr" rid="article-20446.r6">[6]</xref>&#x000a0;Electromyography and nerve conduction studies are suggested for severe or rapidly progressive symptoms or motor weakness.</p>
        <p>Intraepidermal nerve fiber density is the preferred test&#x000a0;for small fiber neuropathy evaluation. Intraepidermal nerve fiber density measurement by skin biopsy&#x000a0;can be considered in patients with idiopathic cases. The number and morphology of axons within the epidermis can be evaluated, and intraepidermal nerve fiber density is compared to age-dependent normal values.<xref ref-type="bibr" rid="article-20446.r46">[46]</xref><xref ref-type="bibr" rid="article-20446.r47">[47]</xref></p>
        <p>Minor symptoms may not need laboratory workup. Persistent unexplained symptoms may warrant laboratory investigation, including serum glucose, hemoglobin A1c, complete blood count, erythrocyte sedimentation rate, rapid plasma reagin, serum electrophoresis, and vitamin B1, B6, and B12 levels.</p>
      </sec>
      <sec id="article-20446.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>DPN management consists of several strategies, including preventative measures (eg, patient education, proper foot care, correct shoe wear, and annual foot exam), glucose control, dietary modifications, weight loss, and pain control.&#x000a0;Many patients with neuropathy have mild to moderate numbness symptoms yet retain protective sensation in their feet. Patients may only need reassurance and education regarding the cause of the&#x000a0;numbness. Periodic follow-up is essential. Peripheral arterial disease and radiculopathy should be ruled out. With improved glycemic control, paresthesias and dysesthesias may diminish within&#x000a0;one year. In 2022, the Current Pain and Headache Reports proposed a treatment algorithm for painful diabetic neuropathy.<xref ref-type="bibr" rid="article-20446.r48">[48]</xref> The algorithm is divided into conservative, pharmacologic, and interventional therapies, subcategorized as first, second, and third-line treatment.</p>
        <p>
<bold>Conservative Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>First-line therapy: </bold>Physical therapy
<list list-type="bullet"><list-item><p>Weight-bearing exercises</p></list-item><list-item><p>Tai chi massage therapy</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Second-line therapy:</bold> Health management
<list list-type="bullet"><list-item><p>Optimization of glucose</p></list-item><list-item><p>Properly manage comorbidities</p></list-item><list-item><p>Weight loss</p></list-item><list-item><p>Healthy diet</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Third-line therapy: </bold>Minimally invasive treatment
<list list-type="bullet"><list-item><p>Acupuncture</p></list-item><list-item><p>Transcutaneous electrical nerve stimulation (TENS)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Pharmacological Therapy</bold></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>First-line agents </bold>
<list list-type="bullet"><list-item><p>Gabapentinoids (eg, pregabalin and gabapentin)</p></list-item><list-item><p>Duloxetine</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Second-line agents</bold>
<list list-type="bullet"><list-item><p>Serotonin and norepinephrine reuptake inhibitors (eg, venlafaxine)</p></list-item><list-item><p>Tricyclic antidepressants (eg, amitriptyline)</p></list-item><list-item><p>Tapentadol</p></list-item><list-item><p>Capsaicin patch&#x000a0;8%</p></list-item><list-item><p>Lidocaine patch&#x000a0;5%</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Third- and Fourth-line agents </bold>
<list list-type="bullet"><list-item><p>Tramadol</p></list-item><list-item><p>Opioid</p></list-item><list-item><p>Intravenous agents (eg, lidocaine, ketamine)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Interventional Therapy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>First-line therapy: </bold>Dorsal column spinal cord stimulation
<list list-type="bullet"><list-item><p>Typically 10 kHz</p></list-item><list-item><p>Tonic waveforms</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Second-line therapy: </bold>Other neuromodulation options
<list list-type="bullet"><list-item><p>Burst spinal cord stimulation</p></list-item><list-item><p>Dorsal root ganglion spinal cord stimulation</p></list-item><list-item><p>Peripheral nerve stimulation</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Third-line therapy: </bold>Intrathecal drug delivery system
<list list-type="bullet"><list-item><p>Intrathecal morphine, fentanyl, or hydromorphone</p></list-item><list-item><p>Intrathecal ziconatide</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>DPN can affect other body areas, including the digestive, endocrine, and vascular systems. Diabetic gastroparesis may be managed with erythromycin and metoclopramide.<xref ref-type="bibr" rid="article-20446.r49">[49]</xref><xref ref-type="bibr" rid="article-20446.r50">[50]</xref>&#x000a0;Tegaserod is a newer agent but is only available on an emergency basis because of serious adverse cardiac effects.<xref ref-type="bibr" rid="article-20446.r51">[51]</xref>&#x000a0;Erectile dysfunction is managed with phosphodiesterase inhibitors, but not everyone has a response. A penile prosthesis may be of benefit.<xref ref-type="bibr" rid="article-20446.r52">[52]</xref>&#x000a0;Orthostatic hypotension may be managed by increased salt and fluid intake and compression stockings. If that fails, steroids may be required.&#x000a0;Glycopyrrolate is used to manage sweating but often does not work.<xref ref-type="bibr" rid="article-20446.r53">[53]</xref></p>
        <p>
<bold>Alternative Therapies</bold>
</p>
        <p>Some patients may also benefit from supplements, but studies are scarce. Omega-3 polyunsaturated fatty acid oral supplements (ie, fish oil) have perhaps the best evidence in attenuating sensory loss and reducing the incidence of peripheral neuropathy.<xref ref-type="bibr" rid="article-20446.r54">[54]</xref> One randomized controlled trial reported a significant increase in corneal nerve fiber length in patients with dry eye disease compared to placebo.<xref ref-type="bibr" rid="article-20446.r55">[55]</xref>&#x000a0;Several studies have linked vitamin D deficiency with an increased risk for diabetic peripheral neuropathy, diabetic ulcer, and cardiovascular autonomic neuropathy.<xref ref-type="bibr" rid="article-20446.r56">[56]</xref> In addition, a single high-dose intramuscular injection of vitamin D supplementation 600,000 IU has significantly improved patients' quality of life and perception of foot problems.<xref ref-type="bibr" rid="article-20446.r57">[57]</xref> There is moderate evidence that alpha lipoic acid supplementation decreases pain with little to no adverse effects.<xref ref-type="bibr" rid="article-20446.r58">[58]</xref><xref ref-type="bibr" rid="article-20446.r59">[59]</xref><xref ref-type="bibr" rid="article-20446.r60">[60]</xref>&#x000a0;</p>
        <p>Additionally, although classified as a medical food, the prescription containing L-methyl folate, pyridoxal 5'-phosphate, and methylcobalamin for the dietary management of endothelial dysfunction has significantly improved nerve fiber density and monofilament sensation.<xref ref-type="bibr" rid="article-20446.r61">[61]</xref>&#x000a0;Scant evidence shows that supplementation with vitamins C and E&#x000a0;prevents diabetic complications. There is no evidence that taking vitamin B12 oral supplements improves DPN.<xref ref-type="bibr" rid="article-20446.r62">[62]</xref>&#x000a0;Depleting substance P with topical capsaicin cream may help some&#x000a0;patients who can tolerate the initially increased burning.<xref ref-type="bibr" rid="article-20446.r63">[63]</xref><xref ref-type="bibr" rid="article-20446.r64">[64]</xref><xref ref-type="bibr" rid="article-20446.r65">[65]</xref>&#x000a0;For patients with painful diabetic peripheral neuropathy, a capsaicin 8% patch in serial treatments can provide modest improvements in pain and sleep quality.<xref ref-type="bibr" rid="article-20446.r66">[66]</xref><xref ref-type="bibr" rid="article-20446.r67">[67]</xref></p>
      </sec>
      <sec id="article-20446.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses of DPN include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Alcohol-associated&#x000a0;neuropathy</p>
          </list-item>
          <list-item>
            <p>Nutritional linked neuropathy</p>
          </list-item>
          <list-item>
            <p>Uremic neuropathy</p>
          </list-item>
          <list-item>
            <p>Vasculitic&#x000a0;linked neuropathy</p>
          </list-item>
          <list-item>
            <p>Vitamin B12 deficiency</p>
          </list-item>
          <list-item>
            <p>Toxic metal neuropathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20446.s11" sec-type="Staging">
        <title>Staging</title>
        <p>While numerous classifications have attempted to categorize different types of diabetic neuropathies, most experts agree that a classification based on the clinical manifestation is the most appropriate.<xref ref-type="bibr" rid="article-20446.r68">[68]</xref> The following classification of diabetic neuropathies described initially by Thomas&#x000a0;is the most accepted today:</p>
        <list list-type="bullet">
          <list-item>
            <p>Rapidly reversible
<list list-type="bullet"><list-item><p>hyperglycemic neuropathy</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Generalized symmetrical polyneuropathies
<list list-type="bullet"><list-item><p>Chronic sensorimotor&#x000a0;</p></list-item><list-item><p>Acute sensory</p></list-item><list-item><p>Autonomic</p></list-item><list-item><p>Prediabetic or impaired glucose tolerance neuropathy</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Focal and multifocal neuropathies
<list list-type="bullet"><list-item><p>Cranial</p></list-item><list-item><p>Thoracolumbar radiculoneuropathy</p></list-item><list-item><p>Focal limb</p></list-item><list-item><p>Proximal motor (eg, amyotrophy)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Superimposed chronic inflammatory demyelinating neuropathy&#x000a0;<xref ref-type="bibr" rid="article-20446.r69">[69]</xref></p>
          </list-item>
        </list>
        <p>The most common type of DPN is generalized symmetrical sensorimotor polyneuropathy.<xref ref-type="bibr" rid="article-20446.r70">[70]</xref>&#x000a0;The staging of diabetic neuropathy was described by Dyck&#x000a0;and divided into 4 stages:<xref ref-type="bibr" rid="article-20446.r71">[71]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 0: no neuropathy</p>
          </list-item>
          <list-item>
            <p>Stage 1: asymptomatic neuropathy</p>
          </list-item>
          <list-item>
            <p>Stage 2: symptomatic neuropathy</p>
          </list-item>
          <list-item>
            <p>Stage 3: disabling neuropathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20446.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Poorly treated diabetics have higher morbidity and complication rates associated with DPN than well-controlled diabetics. DPN often leads to skin breakdown, infection, ulceration, and eventually to amputation. Further, the treatment of DPN is not satisfactory, and adverse cardiac events are common. Less than a third of patients achieve reasonable pain control. For most patients with DPN, the quality of life is poor.</p>
      </sec>
      <sec id="article-20446.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Common complications of DPN include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Amputations of the toes, foot, or leg</p>
          </list-item>
          <list-item>
            <p>Infections of the foot</p>
          </list-item>
          <list-item>
            <p>Falls secondary to dizziness</p>
          </list-item>
          <list-item>
            <p>Diarrhea, failure to thrive, and dehydration</p>
          </list-item>
          <list-item>
            <p>Pain</p>
          </list-item>
          <list-item>
            <p>Cardiovascular neuropathy can cause death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20446.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Preventative strategies are an essential aspect of DPN management. According to the American Diabetes Association, people with diabetes should have a complete foot examination annually&#x000a0;and a visual examination of the feet at each visit, usually every 3 to 4 months. Patients should be educated on monitoring blood sugar levels and self-examining their feet daily to look for ulcers, wounds, or broken skin. They should also follow a diet plan and take medications on time, as advised by the doctor. Clinicians should make patients aware of the contributing role of alcohol and smoking in peripheral neuropathy and recommend a plan to quit as needed. Moreover, abnormally fitting shoes should not be worn by the patient.</p>
      </sec>
      <sec id="article-20446.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>The lower extremities are especially prone to the repetitive microtrauma-induced complications of polyneuropathy. There is an increased propensity to develop not only recurrent neuropathic ulcers but also Charcot neuroarthropathy and, to a lesser extent, motor neuropathy. Additionally, as patients age, their nails become dystrophic, and the risk of subungual ulcerations, gangrene, and osteomyelitis increases with decreased protective sensation. Periodic pedal-focused examinations are essential. Professional foot care and therapeutic shoes and insoles have helped reduce the lower limb amputation rates in patients with diabetes mellitus.</p>
      </sec>
      <sec id="article-20446.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diabetic neuropathy affects many organ systems and is best managed by an interprofessional team. Because there is no cure for the disorder, the key is prevention. All people with diabetes should have a dietary consult and&#x000a0;receive education on what foods they should eat and what to avoid. The diet should be realistic and focused on lowering blood glucose levels. The patients should also enter a rehabilitation program or some exercise. Losing weight makes it easier to control blood sugars and lowers blood pressure and lipids. A podiatry consult is vital as protection of the foot is necessary. Further, all people with diabetes should be informed about avoiding trauma and undergoing any invasive procedure on the feet without prior clearance from the endocrinologist. In addition, the patient should be told to avoid cold or hot temperatures.</p>
        <p>A nurse proficient in diabetes management should educate the patient about all aspects of diabetes and the importance of euglycemia. Patients should be taught how to monitor their blood glucose&#x000a0;and use portable glucose monitors. The pharmacist should offer education about the medications, their benefits, and their adverse effects.</p>
        <p>Compliance with medication therapy to treat diabetes is vital. Finally, patients who develop neuropathy also tend to&#x000a0;have nephropathy and retinopathy; hence, all people with diabetes should be referred to a nephrologist and ophthalmologist. There should be open communication between the interprofessional team so that all patients are provided with the available standard of care with minimal morbidity. Foot and nail care nurses monitor patients, provide education, and inform the team of the patient's condition. Pharmacists educate patients about the use of medications and the importance of compliance.<xref ref-type="bibr" rid="article-20446.r72">[72]</xref><xref ref-type="bibr" rid="article-20446.r73">[73]</xref>&#x000a0;</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>In general, patients with diabetes mellitus who are not compliant with treatment or undertreated usually tend to&#x000a0;have a poorer outcome than patients who undergo treatment. The neuropathy frequently results in skin breakdown, ulceration, and, eventually, an infection. Amputation of the toes and limbs is not uncommon. However, the actual treatment of diabetic neuropathy is not perfect, and often, most treatments do not work. Complete relief from symptoms of neuropathy is rare. Overall, the mortality rates are highest in patients with diabetes mellitus with autonomic neuropathy, especially those who have cardiac dysfunction. The overall mortality rates are 15% to 30% over 10 years, but there is also significant morbidity from limb amputation. Other symptoms that make the quality of life poor include syncopal attacks, diarrhea, constipation, and continuous pain.<xref ref-type="bibr" rid="article-20446.r70">[70]</xref><xref ref-type="bibr" rid="article-20446.r74">[74]</xref></p>
      </sec>
      <sec id="article-20446.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20446&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20446">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/diabetic-peripheral-neuropathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20446">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20446/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20446">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20446.s18">
        <title>References</title>
        <ref id="article-20446.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Acupuncture for postherpetic neuralgia: Systematic review and meta-analysis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>34</issue>
            <fpage>e11986</fpage>
            <pub-id pub-id-type="pmid">30142834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000c7;akici</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fakkel</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>van Neck</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Verhagen</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Coert</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of treatments for diabetic peripheral neuropathy.</article-title>
            <source>Diabet Med</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>1466</fpage>
            <page-range>1466-1476</page-range>
            <pub-id pub-id-type="pmid">26822889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dewanjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dihingia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dua</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Kalita</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manna</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets.</article-title>
            <source>Eur J Pharmacol</source>
            <year>2018</year>
            <month>Aug</month>
            <day>15</day>
            <volume>833</volume>
            <fpage>472</fpage>
            <page-range>472-523</page-range>
            <pub-id pub-id-type="pmid">29966615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sibbald</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Botros</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Boeni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ayello</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kirsner</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Diabetic foot ulcers: Part I. Pathophysiology and prevention.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>1.e1</fpage>
            <page-range>1.e1-18; quiz 19-20</page-range>
            <pub-id pub-id-type="pmid">24355275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Casellini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>N&#x000e9;voret</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy.</article-title>
            <source>Int Rev Neurobiol</source>
            <year>2016</year>
            <volume>127</volume>
            <fpage>235</fpage>
            <page-range>235-85</page-range>
            <pub-id pub-id-type="pmid">27133153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elafros</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Savelieff</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Viswanathan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Callaghan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments.</article-title>
            <source>Lancet Neurol</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>922</fpage>
            <page-range>922-936</page-range>
            <pub-id pub-id-type="pmid">36115364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baum</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Toyka</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Bl&#x000fc;her</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kosacka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nowicki</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects.</article-title>
            <source>Int J Mol Sci</source>
            <year>2021</year>
            <month>Oct</month>
            <day>07</day>
            <volume>22</volume>
            <issue>19</issue>
            <pub-id pub-id-type="pmid">34639176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Casellini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parson</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Colberg</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Nevoret</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events.</article-title>
            <source>Front Neurosci</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>591</fpage>
            <pub-id pub-id-type="pmid">30210276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sloan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shillo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Selvarajah</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Tracey</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tesfaye</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A new look at painful diabetic neuropathy.</article-title>
            <source>Diabetes Res Clin Pract</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>144</volume>
            <fpage>177</fpage>
            <page-range>177-191</page-range>
            <pub-id pub-id-type="pmid">30201394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Julian</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glascow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Syeed</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Alcohol-related peripheral neuropathy: a systematic review and meta-analysis.</article-title>
            <source>J Neurol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>266</volume>
            <issue>12</issue>
            <fpage>2907</fpage>
            <page-range>2907-2919</page-range>
            <pub-id pub-id-type="pmid">30467601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gwathmey</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nutritional neuropathies.</article-title>
            <source>Muscle Nerve</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-29</page-range>
            <pub-id pub-id-type="pmid">31837157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Willison</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>van Doorn</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Guillain-Barr&#x000e9; syndrome.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Aug</month>
            <day>13</day>
            <volume>388</volume>
            <issue>10045</issue>
            <fpage>717</fpage>
            <page-range>717-27</page-range>
            <pub-id pub-id-type="pmid">26948435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freund</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Margolin</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Toxic Optic Neuropathy From Quinine Overdose.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>258</fpage>
            <page-range>258-261</page-range>
            <pub-id pub-id-type="pmid">31842144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Folgori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Silvestri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbaglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Danesino</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B6 Neonatal Toxicity.</article-title>
            <source>Case Rep Pediatr</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>3171351</fpage>
            <pub-id pub-id-type="pmid">36524152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dayot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moussy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de la Gastine</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goutelle</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[Peripheral neuropathy with hypervitaminosis B6 caused by self-medication].</article-title>
            <source>Rev Med Interne</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-129</page-range>
            <pub-id pub-id-type="pmid">31796339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Bilateral sciatic neuropathy with severe rhabdomyolysis following venlafaxine overdose: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>37</issue>
            <fpage>e12220</fpage>
            <pub-id pub-id-type="pmid">30212953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ly</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Blakeley</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>The Diagnosis and Management of Neurofibromatosis Type 1.</article-title>
            <source>Med Clin North Am</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>1035</fpage>
            <page-range>1035-1054</page-range>
            <pub-id pub-id-type="pmid">31582003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jani-Acsadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ounpuu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pierz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Acsadi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Charcot-Marie-Tooth disease.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>767</fpage>
            <page-range>767-86</page-range>
            <pub-id pub-id-type="pmid">26022174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freeman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Autonomic Peripheral Neuropathy.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-71</page-range>
            <pub-id pub-id-type="pmid">31996622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaku</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berk</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Neuropathy Associated with Systemic Amyloidosis.</article-title>
            <source>Semin Neurol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>578</fpage>
            <page-range>578-588</page-range>
            <pub-id pub-id-type="pmid">31639841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gandhi Mehta</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Caress</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Rudnick</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bonkovsky</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Porphyric neuropathy.</article-title>
            <source>Muscle Nerve</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-152</page-range>
            <pub-id pub-id-type="pmid">33786855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerischer</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Scheibe</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>N&#x000fc;mann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>K&#x000f6;hnlein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>St&#x000f6;lzel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Meisel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute porphyrias - A neurological perspective.</article-title>
            <source>Brain Behav</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>e2389</fpage>
            <pub-id pub-id-type="pmid">34661997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>RMC</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Navis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jette</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Small fiber neuropathy associated with SARS-CoV-2 infection.</article-title>
            <source>Muscle Nerve</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>440</fpage>
            <page-range>440-443</page-range>
            <pub-id pub-id-type="pmid">34766365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saif</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ibrahem</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Eltabl</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of peripheral neuropathy and myopathy in patients post-COVID-19 infection.</article-title>
            <source>Int J Rheum Dis</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>11</issue>
            <fpage>1246</fpage>
            <page-range>1246-1253</page-range>
            <pub-id pub-id-type="pmid">35915515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benstead</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chalk</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Parks</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Dec</month>
            <day>20</day>
            <volume>2014</volume>
            <issue>12</issue>
            <fpage>CD010404</fpage>
            <pub-id pub-id-type="pmid">25525951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Oliveira Santos</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neurology of inflammatory bowel disease.</article-title>
            <source>J Neurol Sci</source>
            <year>2021</year>
            <month>May</month>
            <day>15</day>
            <volume>424</volume>
            <fpage>117426</fpage>
            <pub-id pub-id-type="pmid">33810878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a-Cabo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mor&#x000ed;s</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Peripheral neuropathy: an underreported neurologic manifestation of inflammatory bowel disease.</article-title>
            <source>Eur J Intern Med</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>468</fpage>
            <page-range>468-75</page-range>
            <pub-id pub-id-type="pmid">26211733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seeliger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Prenzler</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Gingele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seeliger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>B&#x000f6;nig</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>S&#x000fc;hs</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stangel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Skripuletz</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Neuro-Sj&#x000f6;gren: Peripheral Neuropathy With Limb Weakness in Sj&#x000f6;gren's Syndrome.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1600</fpage>
            <pub-id pub-id-type="pmid">31354737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seretny</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Currie</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Sena</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Ramnarine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>MacLeod</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.</article-title>
            <source>Pain</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>155</volume>
            <issue>12</issue>
            <fpage>2461</fpage>
            <page-range>2461-2470</page-range>
            <pub-id pub-id-type="pmid">25261162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sa&#x00142;at</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.</article-title>
            <source>Pharmacol Rep</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>508</fpage>
            <page-range>508-527</page-range>
            <pub-id pub-id-type="pmid">32347537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staff</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Grisold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grisold</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Windebank</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Chemotherapy-induced peripheral neuropathy: A current review.</article-title>
            <source>Ann Neurol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>81</volume>
            <issue>6</issue>
            <fpage>772</fpage>
            <page-range>772-781</page-range>
            <pub-id pub-id-type="pmid">28486769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaj&#x00105;czkowska</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kocot-K&#x00119;pska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leppert</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wrzosek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mika</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wordliczek</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Mar</month>
            <day>22</day>
            <volume>20</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">30909387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Braza</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Dillingham</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The incidence of peripheral nerve injury in extremity trauma.</article-title>
            <source>Am J Phys Med Rehabil</source>
            <year>2008</year>
            <month>May</month>
            <volume>87</volume>
            <issue>5</issue>
            <fpage>381</fpage>
            <page-range>381-5</page-range>
            <pub-id pub-id-type="pmid">18334923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noland</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Spinner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Adult Traumatic Brachial Plexus Injuries.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2019</year>
            <month>Oct</month>
            <day>01</day>
            <volume>27</volume>
            <issue>19</issue>
            <fpage>705</fpage>
            <page-range>705-716</page-range>
            <pub-id pub-id-type="pmid">30707114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Kratz</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Karnes</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Litchy</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pach</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Melton</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Service</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.</article-title>
            <source>Neurology</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>817</fpage>
            <page-range>817-24</page-range>
            <pub-id pub-id-type="pmid">8469345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pop-Busui</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boulton</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Bril</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sosenko</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Diabetic Neuropathy: A Position Statement by the American Diabetes Association.</article-title>
            <source>Diabetes Care</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <page-range>136-154</page-range>
            <pub-id pub-id-type="pmid">27999003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hjelm</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Diabetes Mellitus: An Overview in Relationship to Charcot Neuroarthropathy.</article-title>
            <source>Clin Podiatr Med Surg</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>535</fpage>
            <page-range>535-542</page-range>
            <pub-id pub-id-type="pmid">36180186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Djibril</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mossi</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Djagadou</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Balaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tchamdja</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moukaila</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Epidemiological, diagnostic, therapeutic and evolutionary features of diabetic foot: a study conducted at the Medico-surgical Clinic, University Hospital Sylvanus Olympio in Lom&#x000e9;].</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>30</volume>
            <fpage>4</fpage>
            <pub-id pub-id-type="pmid">30123407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghotaslou</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Memar</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Alizadeh</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Classification, microbiology and treatment of diabetic foot infections.</article-title>
            <source>J Wound Care</source>
            <year>2018</year>
            <month>Jul</month>
            <day>02</day>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>434</fpage>
            <page-range>434-441</page-range>
            <pub-id pub-id-type="pmid">30016139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Szendroedi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Benthin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gontscharuk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ackermann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Steingrube</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nowotny</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ssig</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geerling</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ku&#x000df;</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Roden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guthoff</surname>
                <given-names>R</given-names>
              </name>
              <collab>GDS Cohort</collab>
            </person-group>
            <article-title>German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>e303</fpage>
            <page-range>e303-e307</page-range>
            <pub-id pub-id-type="pmid">30238609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mo&#x00163;&#x00103;&#x00163;&#x00103;ianu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bajko</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Voidazan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>B&#x00103;la&#x0015f;a</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stoian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients.</article-title>
            <source>BMC Neurol</source>
            <year>2018</year>
            <month>Aug</month>
            <day>27</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>126</fpage>
            <pub-id pub-id-type="pmid">30149797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doria</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viad&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palomera</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Llad&#x000f3;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huguet</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Reverter</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Serra-Prat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franch-Nadal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mauricio</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Short-term foot complications in Charcot neuroarthropathy: A retrospective study in tertiary care centres in Spain.</article-title>
            <source>Endocrinol Diabetes Nutr (Engl Ed)</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>65</volume>
            <issue>9</issue>
            <fpage>479</fpage>
            <page-range>479-485</page-range>
            <pub-id pub-id-type="pmid">30108031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dash</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>107</volume>
            <fpage>306</fpage>
            <page-range>306-328</page-range>
            <pub-id pub-id-type="pmid">30098549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sloan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Selvarajah</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tesfaye</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>400</fpage>
            <page-range>400-420</page-range>
            <pub-id pub-id-type="pmid">34050323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e8;ne</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Small fiber neuropathy: Diagnosis, causes, and treatment.</article-title>
            <source>Joint Bone Spine</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>553</fpage>
            <page-range>553-559</page-range>
            <pub-id pub-id-type="pmid">29154979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chedid</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brandler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vijayvargiya</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Szarka</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>114</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-154</page-range>
            <pub-id pub-id-type="pmid">30166634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petropoulos</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Ponirakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Almuhannadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing Diabetic Neuropathy: Something Old, Something New.</article-title>
            <source>Diabetes Metab J</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>255</fpage>
            <page-range>255-269</page-range>
            <pub-id pub-id-type="pmid">30136449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Souza</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Barman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abd-Elsayed</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>8</issue>
            <fpage>583</fpage>
            <page-range>583-594</page-range>
            <pub-id pub-id-type="pmid">35716275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shakhatreh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jehangir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Parkman</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Metoclopramide for the treatment of diabetic gastroparesis.</article-title>
            <source>Expert Rev Gastroenterol Hepatol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>711</fpage>
            <page-range>711-721</page-range>
            <pub-id pub-id-type="pmid">31314613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frazee</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Mauro</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Erythromycin in the Treatment of Diabetic Gastroparesis.</article-title>
            <source>Am J Ther</source>
            <year>1994</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-295</page-range>
            <pub-id pub-id-type="pmid">11835102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Rayner</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Horowitz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>1171</fpage>
            <page-range>1171-86</page-range>
            <pub-id pub-id-type="pmid">23663133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mobley</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Khera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in the treatment of erectile dysfunction.</article-title>
            <source>Postgrad Med J</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>1105</issue>
            <fpage>679</fpage>
            <page-range>679-685</page-range>
            <pub-id pub-id-type="pmid">28751439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palma</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kaufmann</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Management of Orthostatic Hypotension.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>154</fpage>
            <page-range>154-177</page-range>
            <pub-id pub-id-type="pmid">31996627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>De Silva</surname>
                <given-names>MEH</given-names>
              </name>
              <name>
                <surname>MacIsaac</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kamel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Busija</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Downie</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis.</article-title>
            <source>Nutr Rev</source>
            <year>2020</year>
            <month>Apr</month>
            <day>01</day>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-341</page-range>
            <pub-id pub-id-type="pmid">31532492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chinnery</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Naranjo Golborne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Downie</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>473</fpage>
            <page-range>473-481</page-range>
            <pub-id pub-id-type="pmid">28295445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Putz</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tordai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hajd&#x000fa;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>V&#x000e1;gi</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Kempler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000e9;keffy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rei</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Istenes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Horv&#x000e1;th</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stoian</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Papanas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kempler</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D in the Prevention and Treatment of Diabetic Neuropathy.</article-title>
            <source>Clin Ther</source>
            <year>2022</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>813</fpage>
            <page-range>813-823</page-range>
            <pub-id pub-id-type="pmid">35428527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alam</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Fawwad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shaheen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tahir</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Basit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation.</article-title>
            <source>J Diabetes Res</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>7928083</fpage>
            <pub-id pub-id-type="pmid">29445752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esposito</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ugo Garzarella</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santarcangelo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Di Minno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dacrema</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sacchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piccinocchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Piccinocchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Daglia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>144</volume>
            <fpage>112308</fpage>
            <pub-id pub-id-type="pmid">34649217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeffrey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samraj</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Raj</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials.</article-title>
            <source>Curr Diabetes Rev</source>
            <year>2021</year>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>e011821190404</fpage>
            <pub-id pub-id-type="pmid">33461470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <article-title>Retraction. Alpha-lipoic acid supplementation and diabetes.</article-title>
            <source>Nutr Rev</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>70</volume>
            <issue>8</issue>
            <fpage>482</fpage>
            <pub-id pub-id-type="pmid">22835141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fonseca</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Lavery</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Thethi</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Daoud</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>DeSouza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ovalle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Denham</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bottiglieri</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sheehan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rosenstock</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.</article-title>
            <source>Am J Med</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>126</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-9</page-range>
            <pub-id pub-id-type="pmid">23218892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayabalan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B supplementation for diabetic peripheral neuropathy.</article-title>
            <source>Singapore Med J</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>55</fpage>
            <page-range>55-9</page-range>
            <pub-id pub-id-type="pmid">26892473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnasamy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abell</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Diabetic Gastroparesis: Principles and Current Trends in Management.</article-title>
            <source>Diabetes Ther</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>Suppl 1</issue>
            <fpage>1</fpage>
            <page-range>1-42</page-range>
            <pub-id pub-id-type="pmid">29934758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia-Klepzig</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-R&#x000ed;os</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Manu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ahluwalia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>L&#x000fc;demann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meloni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lacopi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>De Buruaga</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Bouillet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vouillarmet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>L&#x000e1;zaro-Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Van Acker</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Perception of diabetic foot ulcers among general practitioners in four European countries: knowledge, skills and urgency.</article-title>
            <source>J Wound Care</source>
            <year>2018</year>
            <month>May</month>
            <day>02</day>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>310</fpage>
            <page-range>310-319</page-range>
            <pub-id pub-id-type="pmid">29738299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iqbal</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Azmi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferdousi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cuthbertson</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Alam</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy.</article-title>
            <source>Clin Ther</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>828</fpage>
            <page-range>828-849</page-range>
            <pub-id pub-id-type="pmid">29709457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Robinson-Papp</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stoker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Snijder</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Schregardus</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Lambourg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.</article-title>
            <source>J Pain</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-53</page-range>
            <pub-id pub-id-type="pmid">27746370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinik</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Perrot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vinik</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Pazdera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stoker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Snijder</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van der Stoep</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.</article-title>
            <source>BMC Neurol</source>
            <year>2016</year>
            <month>Dec</month>
            <day>06</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>251</fpage>
            <pub-id pub-id-type="pmid">27919222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulton</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Diabetic neuropathy: classification, measurement and treatment.</article-title>
            <source>Curr Opin Endocrinol Diabetes Obes</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-5</page-range>
            <pub-id pub-id-type="pmid">17940432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Classification, differential diagnosis, and staging of diabetic peripheral neuropathy.</article-title>
            <source>Diabetes</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>46 Suppl 2</volume>
            <fpage>S54</fpage>
            <page-range>S54-7</page-range>
            <pub-id pub-id-type="pmid">9285500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zafeiri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsioutis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kleinaki</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Manolopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ioannidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dimitriadis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics of Patients with co-Existent Diabetic Peripheral Neuropathy and Depression: A Systematic Review.</article-title>
            <source>Exp Clin Endocrinol Diabetes</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">30257266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dyck</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Detection, characterization, and staging of polyneuropathy: assessed in diabetics.</article-title>
            <source>Muscle Nerve</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-32</page-range>
            <pub-id pub-id-type="pmid">3277049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferraresi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Casini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Caminiti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Losurdo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Clerici</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Multidisciplinary approach to diabetic foot: a challenge of expertises].</article-title>
            <source>G Ital Cardiol (Rome)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>495</fpage>
            <page-range>495-503</page-range>
            <pub-id pub-id-type="pmid">30087510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>&#x000c1;lvarez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>L&#x000e1;zaro-Mart&#x000ed;nez</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Analysis of recurrent ulcerations at a multidisciplinary diabetic Foot unit after implementation of a comprehensive Foot care program.</article-title>
            <source>Endocrinol Diabetes Nutr (Engl Ed)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>8</issue>
            <fpage>438.e1</fpage>
            <page-range>438.e1-438.e10</page-range>
            <pub-id pub-id-type="pmid">29914816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20446.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bonfanti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grugni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4&#x000a0;Weeks of Treatment.</article-title>
            <source>Adv Ther</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>1585</fpage>
            <page-range>1585-1597</page-range>
            <pub-id pub-id-type="pmid">30206821</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
